Skip to content

    Recently Viewed

      Listening...

      Eyes showing how contact lenses respond to changing light conditions via a photochromic filter

      Acuvue Oasys® with Transitions™ Light Intelligent Technology™ contact lenses named one of Time’s Best Inventions of 2018

      This first-of-its-kind innovation has a dynamic photochromic filter that responds to changing light conditions.

      Share Article
      share to

      Picture this: You pop in your contact lenses before heading outside on a sunny day and don’t immediately squint—because your lenses have automatically darkened to filter out the bright light, seamlessly keeping your eyes comfortable and your vision crisp.

      Sounds futuristic, right?

      Not anymore, with the development of Acuvue Oasys® with Transitions™ Light Intelligent Technology™. And while the product won’t be available until the first half of 2019, it’s already causing a stir: The contact lenses were just chosen as one of Time‘s Best Inventions of 2018.

      Better sight through Light Intelligent Technology

      Inset- Acuvue Oasys News Item- Acuvue Oasys Contact lens

      A photochromic filter allows the lens to respond to changes in light and darken accordingly (shown left to right)

      Each year, Time seeks out lifestyle innovations that carry the promise of making the world, in their words, “better, smarter and even a bit more fun.” You can check out last year’s winners here.

      The revolutionary Acuvue Oasys with Transitions Light Intelligent Technology lenses experience fits the bill, thanks to a dynamic photochromic filter that responds to changing light conditions—indoors and out—by reducing exposure to bright light, filtering out blue light, blocking UV rays and, of course, providing vision correction at the same time. (Learn more about Acuvue, including safety information.)

      We believe it will redefine how people think about wearing contact lenses, and we are excited to see the world react to this first-of-its-kind innovation.
      Ashley McEvoy

      It’s the brainchild of a partnership between Johnson & Johnson Vision Care, Inc. and Transitions Optical—the leading provider of photochromic smart adaptive eyeglass lenses worldwide. In April of this year, the lenses were cleared by the U.S. Food and Drug Administration (FDA) as the first to be invented with light adaptive technology.

      “The introduction of Acuvue Oasys with Transitions Light Intelligent Technology has been 15-plus years in the making, and its distinction as a Time Best Invention of 2018 is incredibly meaningful to the many researchers, scientists, engineers and others who have seen the product from its initial concept,” says Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson. “We believe it will redefine how people think about wearing contact lenses, and we are excited to see the world react to this first-of-its-kind innovation.”

      Considering getting contacts?

      Check out this new wearer guide, packed with great tips for safely and comfortably using contact lenses.

      More from Johnson & Johnson

      Caring & giving
      Sam Seavey piloting an aircraft from the cockpit

      3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection

      In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.